Key takeaways

  • Ozempic microdosing involves taking a lower dose of the medication than is typically recommended, but research on its safety and effectiveness is limited.
  • Some potential benefits of microdosing may include reduced drug costs and fewer gastrointestinal side effects, but it’s unclear if it provides the same cardiovascular benefits as standard doses.
  • If you’re considering microdosing Ozempic, it’s important to consult a doctor to discuss the potential benefits and risks and to help ensure safe practices.

Ozempic microdosing is not a recommended dosing schedule for the drug and it not backed by scientific research. Microdosing is a trend where people use smaller-than-prescribed weekly doses of a drug like Ozempic. This often is done by “counting clicks” on the pen.

Someone may choose to use a microdosing schedule with Ozempic to help reduce side effects, such as nausea, or save money.

Ozempic microdosing involves taking a lower dosage of the drug than the manufacturer or the FDA recommends. The idea behind microdosing any drug is that you may be able to get the same health benefit with a much smaller dosage.

A lower dosage involves either of these alternative dosing regimens:

  • taking a lower dose (amount) of the drug at the recommended frequency
  • taking the recommended dose less frequently

Ozempic comes in an adjustable auto-injector pen. When you’re ready to inject your dose, you turn the pen dial until the dose counter shows your prescribed dose in milligrams (mg). You’ll also hear a click every time you turn the dial.

The typical starting dose is 0.25 mg once per week for the first month. Your doctor will gradually increase your weekly dose if necessary.

In theory, you can select a lower Ozempic dose than recommended based on the number of clicks you hear when turning the Ozempic pen dial. There are no specific studies comparing Ozempic microdosing regimens with approved dosages.

The American Diabetes Association (ADA) mentioned alternative dosing approaches in its 2023 report, including the following microdosing chart. That said, these were only suggested as a temporary solution during semaglutide shortages. (Semaglutide is the active ingredient in the brand-name drugs Ozempic and Wegovy.)

The ADA does not endorse microdosing, and there is no strong scientific research to support its safety or effectiveness.

Ozempic’s prescribing information recommends specific once-weekly doses that have been studied for safety and effectiveness. The drug’s manufacturer also advises against relying on the number of clicks to select your prescribed dose. Talk with your doctor if you’re considering any changes to your prescribed dose.

The microdosing chart shows the number of clicks necessary to reach an intermediate dose for each pen strength. These are expressed in mg of the drug per milliliter of solution (mg/mL). For example, the typical weekly dose requires 74 clicks.

Ozempic pen strengthTypical doseIntermediate dosesNumber of clicks
0.25 and 0.5 mg (2 mg/3 mL)0.5 mg• 0.4 mg
• 0.33 mg
• 0.25 mg
• 0.12 mg
• 0.06 mg
• 59
• 49
• 37
• 18
• 9
1 mg (4 mg/3 mL) 1 mg• 0.8 mg
• 0.66 mg
• 0.5 mg
• 0.25 mg
• 0.12 mg
• 59
• 49
• 37
• 18
• 9
2 mg (8 mg/3 mL) 2 mg• 1.6 mg
• 1.33 mg
• 1 mg
• 0.5 mg
• 0.25 mg
• 59
• 49
• 37
• 18
• 9

Ozempic microdosing has not been studied in clinical trials, so it’s unclear how well it works compared with the drug’s recommended dosages. Reports of Ozempic microdosing are mainly anecdotal, such as in these articles from USA Today and The Hollywood Reporter.

Most clinical trials of Ozempic compared once-weekly doses of 0.5 mg and 1 mg for people with type 2 diabetes.

When researchers looked at weight loss, they found that both the 1-mg and 0.5-mg doses were more effective than a placebo (no active drug). Increasing the dosage to 2 mg per week was no more effective for weight loss than 1 mg per week. This means that receiving 0.5 mg or 1 mg of Ozempic per week may be enough to make you lose weight.

Note: Ozempic is not FDA-approved for weight loss. Some doctors may prescribe it off-label for this use. (Off-label use is when doctors prescribe a drug for a purpose other than what it’s approved for.)

Wegovy microdosing

A lower semaglutide dosage may also be effective for weight loss with Wegovy. A preliminary study used a mathematical model to predict that a dosing frequency of every 2 weeks could still result in significant weight loss. The results were compared with Wegovy’s clinical trials, in which participants received 2.4 mg of the drug once per week for 68 weeks.

If you have questions about how well semaglutide microdosing may work for you, talk with your doctor.

Microdosing Ozempic or other GLP-1 agonists has potential benefits and risks. These may vary depending on your condition and medical history.

Benefits of microdosing

Some practical benefits of microdosing include lower drug costs and dosing flexibility in case of semaglutide shortages.

Microdosing may also reduce or ease certain side effects of the drug. Both Ozempic and Wegovy commonly cause gastrointestinal (GI) side effects such as nausea, vomiting, and constipation. In Ozempic studies, some people ended treatment because of GI side effects. A lower dosage may help reduce the risk or severity of these side effects.

Risks of microdosing

Although microdosing may help with weight loss in some people, it’s not known whether this approach is safe or effective for the drugs’ other uses. For example, both Ozempic and Wegovy are approved to reduce the risk of serious cardiovascular problems in certain people.

Microdosing with compounded semaglutide may also pose a risk. During compounding, a healthcare professional (typically, a licensed pharmacist) changes or combines the drug’s ingredients with one or more other drugs. However, due to the potential risks of compounded drugs, the FDA advises using them only if the FDA-approved drug can’t meet your medical needs.

Alternative dosing with adjustable auto-injector pens may also result in dosing errors.

If you’re interested in microdosing Ozempic or any other GLP-1 agonist, talk with a doctor first. You can discuss the benefits and risks and decide whether microdosing is a treatment option for your condition. If you decide to try microdosing, your doctor will advise you on how to do so safely.

Disclaimer: While Medical News Today strives for factual, comprehensive, and current information, this article is not a substitute for a licensed healthcare professional’s expertise. Always consult a doctor before taking or discontinuing any medication. Drug information is subject to change and may not cover all uses, directions, precautions, warnings, interactions, reactions, or adverse effects. The lack of a warning does not guarantee a drug’s safety, effectiveness, or appropriateness for all patients or specific uses. Learn more about our approach to content integrity.